GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CBD Life Sciences Inc (OTCPK:CBDL) » Definitions » Capex-to-Operating-Income

CBD Life Sciences (CBD Life Sciences) Capex-to-Operating-Income : 0.00 (As of Sep. 2015)


View and export this data going back to 2009. Start your Free Trial

What is CBD Life Sciences Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

CBD Life Sciences's Capital Expenditure for the three months ended in Sep. 2015 was $0.00 Mil. Its Operating Income for the three months ended in Sep. 2015 was $-0.02 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


CBD Life Sciences Capex-to-Operating-Income Historical Data

The historical data trend for CBD Life Sciences's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CBD Life Sciences Capex-to-Operating-Income Chart

CBD Life Sciences Annual Data
Trend Dec11 Dec12 Dec13 Dec14
Capex-to-Operating-Income
- - - -

CBD Life Sciences Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CBD Life Sciences's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, CBD Life Sciences's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CBD Life Sciences's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CBD Life Sciences's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where CBD Life Sciences's Capex-to-Operating-Income falls into.



CBD Life Sciences Capex-to-Operating-Income Calculation

CBD Life Sciences's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2014 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -0.761
=N/A

CBD Life Sciences's Capex-to-Operating-Income for the quarter that ended in Sep. 2015 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -0.022
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CBD Life Sciences  (OTCPK:CBDL) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


CBD Life Sciences Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of CBD Life Sciences's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


CBD Life Sciences (CBD Life Sciences) Business Description

Traded in Other Exchanges
N/A
Address
10853 N. Frank Llyod Wright Boulevard, Suite 108, Scottsdale, AZ, USA, 85259
CBD Life Sciences Inc is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products. The company is also in the process of developing an anti-aging skin product line.